Clinical trial · Observational
A Contemporary Review of Surgical Approaches in Pelvic Exenterative Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Minimally-invasive surgery (MIS) techniques have revolutionised the approach to rectal cancer surgery. With increasing experience, surgeons have began to utilise these platforms increasingly in the context of pelvic exenteration (PE). This observational retrospective review plans to assess the volume of PE being performed on a global basis and to assess the comparative outcomes associated with each technique in order to assess the optimal approach to radical pelvic surgery.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Pelvic Malignancy | — | UNRESOLVED | — |
| Locally Advanced Rectal Cancer | Malignant Rectal Neoplasm | CURATED_BROADER | 0.78 |
| Pelvic Exenteration | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (3)
- label
- Open
- description
- Patients who underwent an open approach to pelvic exenteration
- label
- Laparoscopic
- description
- Patients who underwent a laparoscopic approach to pelvic exenteration
- label
- Robotic
- description
- Patients who underwent a robotically-assisted pelvic exenteration
Primary outcomes (1)
- measure
- Resection status
- timeFrame
- July 2016 - July 2021
- description
- Completeness of the surgical resection (R0, R1 or R2)
Secondary outcomes (7)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven locally advanced or recurrent RECTAL cancer * Aged over 18 years * Undergoing a multi-visceral extended pelvic resection * Procedure took place within the specified timeframe (July 2016 - July 2021) Exclusion Criteria: * Extra-pelvic/ non-resectable metastatic or peritoneal disease * Palliative pelvic exenteration * Insufficient patient follow-up data
References
Publications (0)
Data not yet available